Euan Thomson Summary

Euan is an operating partner at Khosla Ventures, where he focuses on healthcare. During his tenure at the firm, he has worked with Quanttus, CellScope, Zyomed, EyeNetra, Ginger.io, and Lumiata among many others. Euan currently serves as the interim CEO of Alivecor, which has developed a device that can turn any smartphone into a clinical-quality mobile heart monitor.

Previously, Euan trained as a physicist at the University of London, where he devoted more than fifteen years to research, teaching, clinical practice and administration within the United Kingdom’s health care system. In parallel, he formed a successful consultancy practice, providing advice for companies and hospitals on scientific development, product marketing and management with premier clients including Varian Medical Systems and Radionics, Inc., to name a few.

In 2002, Euan joined Accuray Inc., where he secured worldwide clinical acceptance for CyberKnife® Radiosurgery and dramatically improved their intellectual property portfolio. Further, he built distribution channels in more than 80 countries and executed a strategic sales alliance with Siemens Healthcare and consummated the successful acquisition of TomoTherapy®, Inc. At Accuray and, Photoelectron Inc., where he served as president and CEO, Euan initiated and directed a host of sophisticated financial transactions including private and public investments including initial public offerings.

Euan holds a bachelor’s of science degree in physics with medical applications, a master’s of science degree in radiation physics and a doctor of philosophy degree in physics from the University of London. He also has authored numerous scientific papers and holds six U.S. patents.